---
name: TFS HealthScience
slug: tfscro
site: cro
website_domain: tfscro.com
summary: Global mid-size CRO specializing in dermatology, internal medicine, neuroscience, oncology, and ophthalmology with Phase I-IV clinical development, real-world evidence studies, and flexible resourcing solutions across 600+ experts in Europe, North America, and Australia. Headquartered in Lund, Sweden.
tagline: Global mid-size CRO combining full-service clinical development with flexibility and local expertise across dermatology, oncology, neuroscience, and ophthalmology.
founded_year: 1996
employee_count_band: 201-1000
employee_count_label: 201–1,000
parent_name: 
parent_slug: 
hq_country: SE
tier2_domain_verified: false
updated_at: 2026-06-17T07:00:37.536Z
services_count: 11
modalities_count: 3
indications_count: 5
locations_count: 14
review_signal_gate: closed
generated_by: BioBM Editorial AI
---

# TFS HealthScience

Global mid-size CRO combining full-service clinical development with flexibility and local expertise across dermatology, oncology, neuroscience, and ophthalmology.

Listed on cro.directory.

## Summary

Global mid-size CRO specializing in dermatology, internal medicine, neuroscience, oncology, and ophthalmology with Phase I-IV clinical development, real-world evidence studies, and flexible resourcing solutions across 600+ experts in Europe, North America, and Australia. Headquartered in Lund, Sweden.

## At a glance

- Founded: 1996
- Employees (est.): 201–1,000
- HQ country: SE

## Services

- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Regulatory Affairs
- Medical Writing
- Pharmacovigilance & Drug Safety
- Data Management & eClinical
- Oncology Specialty Services
- CNS Specialty Services

## Modalities

- Small Molecule
- Biologics (Other)
- Vaccine

## Indications

- Dermatology
- Oncology
- Neurology
- Psychiatry
- Ophthalmology

## Locations

- Headquarters, Lund, Skåne, Sweden
- Office, Copenhagen, Capital Region, Denmark
- Phase I & PET Imaging, Stockholm, Stockholm, Sweden
- Office, Uxbridge, England, United Kingdom
- Office, Amsterdam, North Holland, Netherlands
- Office, Berlin, Berlin, Germany
- Office, Paris, Île-de-France, France
- Office, Milan, Lombardy, Italy
- Office, Madrid, Madrid, Spain
- Office, Toronto, Ontario, Canada
- Office, Lisbon, Lisbon, Portugal
- Office, Tel Aviv, Tel Aviv, Israel
- Operations, North America, North America, United States
- Operations, Australia, Australia, Australia

## Long description

## Overview

TFS HealthScience is a global contract research organization founded in 1996 in Lund, Sweden, and now operating across Europe, North America, and Australia with over 600 professionals. The company combines full-service clinical development capabilities with the agility and flexibility of a mid-size CRO.

## Therapeutic Expertise

TFS specializes in five core therapeutic areas:

- **Dermatology** — skin conditions including eczema, psoriasis, and melanoma
- **Internal Medicine** — broad range of internal health conditions
- **Neuroscience** — complex neurological and psychiatric disorders
- **Oncology** — end-to-end cancer treatment solutions from regulatory strategy through trial execution
- **Ophthalmology** — clinical development and commercialization for drugs, devices, and diagnostics in vision care

## Service Lines

**Clinical Development**
Scientific and operational expertise spanning regulatory strategy and clinical operations for Phases I–III, post-authorization studies, and real-world evidence (RWE) programs. TFS has 20+ years of experience designing and executing global non-interventional studies across nearly 7,000 sites worldwide.

**Resourcing Solutions**
Flexible staffing and recruitment services ranging from single critical hires to fully managed teams, enabling clients to insource expertise while maintaining focus on core innovation.

**Functional Service Provider (FSP) Model**
TFS was the first CRO in Europe to establish an FSP business model (1997) and continues to offer fit-for-purpose outsourcing models for clinical workforce management.

**Specialized Capabilities**
- Virtual and decentralized study solutions leveraging digital platforms to reach participants globally
- Phase I operations (established 2003 in partnership with Karolinska University Hospital, Stockholm)
- Real-world evidence and pragmatic Phase IV trials
- Expert and talent solutions through a network of key opinion leaders and subject matter experts
- Medical writing, regulatory affairs, and pharmacovigilance services (strengthened through 2005 acquisition of CDC Clinical Data Care)
- Data management and EDC solutions (in-house development and partnerships with Medidata Rave, Veeva, and Duke Clinical Research Institute)

## Growth and Acquisitions

TFS has expanded through strategic acquisitions including SCIderm (dermatology specialist, 2016), Beardsworth Consulting Group (oncology and vaccine niche, 2013), and Appletree CI Group (ophthalmology and medical devices, 2023). The company is majority-owned by Ratos (acquired 100% by 2019).

_Profile last updated: 2026-06-17T07:00:37.536Z. Profile facts may include AI-assisted enrichment._

Auto-generated by BioBM Editorial AI for machine-readable profile access.